(IN BRIEF) According to an independent report, the cost of prescription medicines to the NHS in England reached a record high of £17.2 billion in the financial year 2021-2022. The report reveals that NHS spending on branded medicines has been … Read the full press release
Posted in Education, Government, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Beth Woods, cancer drugs, cost of prescription medicines, COVID-19 vaccines, Dr Huseyin Naci, Dr James Lomas, e Voluntary Scheme for Branded Medicines Pricing and Access, immunosuppression, London School of Economics and Political Science, London School of Hygiene & Tropical Medicine, LSE, LSHTM, malignant disease, medicines, NHS, REPORT, respiratory system disorders, University of York, VPAS
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
